Clinical Trials in Philadelphia

Showing 3241-3260 of 17,926 trials

An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease

NCT05757141

Fosigotifator is an investigational drug being researched for the treatment of Vanishing White Matter disease in adult, pediatric and infant participants. This is a 201-week, open-label, multiple cohort study enrolling adults, pediatric and infant participants with Vanishing White Matter disease. Participants will attend regular visits during the course of the study and complete medical assessments, blood tests, questionnaires, and be evaluated for side effects.

Vanishing White Matter Disease

Calico Life Sciences LLC50 participantsStarted Mar 2023

Boston, Massachusetts, United States • Philadelphia, Pennsylvania, United States • Salt Lake City, Utah, United States +2 more locations

Active Not RecruitingPhase 3< 1 mile

A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

NCT04204616

The primary purpose of this study is to assess the long-term safety of nemolizumab (CD14152) in participants with prurigo nodularis (PN).

Prurigo Nodularis

Galderma R&D500 participantsStarted Jan 2021

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Fountain Valley, California, United States +161 more locations

An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease

A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Find Trials by Condition in Philadelphia

CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)

Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer

huCART19-IL18 in CD19+ Cancers

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers

A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer

Transcranial Direct Current Stimulation for Depression

A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo

Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002)

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.

Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients

Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer

Return of Genomic Results and Aggregate Penetrance in Population-Based Cohorts

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia